HCWB
HCW Biologics Inc.Company with tickers: HCWB
CIK
1828673
CUSIP
40423R204
Shares Outstanding
7,161,150
13F Activity (30d)
13 filings
13 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $6,500,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | $11,071 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Gross Profit | $6,531,930 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Expenses | $3,296,221 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $1,257,948 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $3,235,709 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $3,472,480 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $0.37 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $0.37 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |